Lost in translation: “Smart early clinical development with the end in mind” Part 1 Featured Image

Lost in translation: “Smart early clinical development with the end in mind” Part 1

17 May 23


Lost in translation will address efficiently progressing innovative medicines from research into pre-clinical and first-in-man studies is important in maximising value creation in any biotech or Pharma company. That progress however must be based on robust studies to increase the probability of success. This BioWednesday event, led by tranScrip discusses how investors and entrepreneurs evaluate small companies for investment. We will give you hints and tips to take away that will help inform your critical decisions. We will explore how companies managed to navigate the hurdles towards the clinic, what made the difference, pain points, and bugbears.

View part 2 of the webinar here.

Contact Us

Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.